RxAnte, a provider of analytics, software, and clinical services for pharmacy care management, announced it has secured a strategic growth investment from Primus Capital as it looks to scale its value-based pharmacy programs and expand clinical offerings for health plans and members with complex drug therapy needs.
Financial terms were not disclosed. RxAnte said the investment comes as Mosaic Pharmacy Service, its technology-enabled pharmacy care management subsidiary, accelerates growth by delivering “high-touch” pharmacy care for medically complex and vulnerable populations.
RxAnte said it pioneered the use of healthcare data and advanced analytics to identify risk of unsafe medication use, run programs designed to improve prescribing and adherence, and measure outcomes in vulnerable groups. The company said it expects to manage more than 34 million lives in 2026 through partnerships with regional and national health plans.
The company pointed to peer-reviewed outcomes studies conducted with UPMC Health Plan that it said demonstrate Mosaic improves member health, reduces hospitalizations, lowers medical costs, and lifts quality scores. RxAnte said UPMC, which has served as a partner since 2016, supportedthe development of its model focused on individualized and coordinated pharmacy care for patients facing both medical complexity and social vulnerability.
Primus Capital, which invests in healthcare technology and services companies, said it views RxAnte as a market leader in pharmacy care management and plans to support continued product innovation and expansion.
RxAnte describes its mission as helping people on complex medication regimens live longer, healthier lives by combining population-level analytics with clinical services delivered through Mosaic for health plans and their members.
KEY QUOTES:
“Our partnership with Primus Capital marks a pivotal moment in RxAnte’s journey. As drug prices continue to climb and medication use continues to be a focus of quality measurement, pharmacy care needs to be more individualized and coordinated than ever before. With the pioneering support and guidance of UPMC, we developed a truly unique and value-based model of pharmacy care for medically complex and socially vulnerable patients.”
Josh Benner, Co-Founder and CEO, RxAnte
“Primus shares our vision around data-driven pharmacy care management as one of the greatest opportunities to improve health outcomes and reduce total cost of care. This new partnership with Primus will help us accelerate bringing RxAnte solutions to more patients.”
Brent Burns, Executive Vice President, UPMC Enterprises
“We are thrilled to partner with the RxAnte team. RxAnte has built a unique, data-driven platform that solves one of the most persistent and costly challenges in healthcare. We look forward to supporting their continued innovation and expansion as they re-shape the role of pharmacy in supporting better outcomes.”
Phil Molner, Managing Partner, Primus Capital
